Lawmakers have sights on middlemen blamed for rising drug costs

Lawmakers have sights on middlemen blamed for rising drug costs
© Getty Images

With public outrage growing over the rising costs of prescription drugs, Congress is targeting the middlemen they say are to blame. 

Specifically, lawmakers are moving to ban “gag clauses” that prohibit pharmacies from telling customers they can save money on a drug if they pay with cash instead of using their health insurance. 

These clauses are sometimes included in contracts between pharmacies and pharmacy benefit managers — the middlemen who act as negotiators between drug companies and insurers.

ADVERTISEMENT
The clauses prevent a pharmacist from telling a customer if their $20 co-pay is higher than the pharmacy’s cash price for a drug. 

“Pharmacists want to be able to give their consumers information about what’s the best way to buy the medication they need, but the gag rule prohibits the pharmacists from doing that,” said Rep. Peter WelchPeter Francis WelchDems struggle with unity amid leadership tensions New Dem star to rattle DC establishment Overnight Defense: Defense spending bill amendments target hot-button issues | Space Force already facing hurdles | Senators voice 'deep' concerns at using military lawyers on immigration cases MORE (D-Vt.), co-sponsor of a House bill that would ban gag clauses. 

The practice of charging a co-pay that is higher than the cash price of a drug is called a “clawback.”

The National Community Pharmacists Association (NCPA), one of the groups pushing for a federal “gag clause” ban, notes that it’s the pharmacy benefit managers or “PBMs” that keep this extra money, not the pharmacies. 

“Obviously that’s intended to fatten the profits of the PBMs at the expense of the consumers, and it’s interfering with the trusting relationship pharmacists have with their clients,” Welch said. 

Bipartisan bills in the House and Senate, sponsored by Sen. Susan CollinsSusan Margaret CollinsThe Hill's Morning Report — Russia furor grips Washington Overnight Health Care: Novartis pulls back on drug price hikes | House Dems launch Medicare for All caucus | Trump officials pushing ahead on Medicaid work requirements Senate panel to vote next week on banning 'gag clauses' in pharmacy contracts MORE (R-Maine) and Rep. Buddy CarterEarl (Buddy) Leroy CarterOvernight Health Care — Sponsored by PCMA — DOJ move against ObamaCare sets off frenzy Lawmakers have sights on middlemen blamed for rising drug costs Tax reform has provided a ripe opportunity for American workers MORE (R-Ga.), wouldn’t ban clawbacks, but would ban gag clauses so pharmacists can tell their customers whether they’d save money on their prescription if they pay with cash instead of their insurance. 

The Collins bill is expected to come up for a committee vote on June 20. 

A spokesperson for Carter said the congressman is still continuing to push for a hearing and building member support. 

It’s difficult to know how often customers are charged more for their co-pay than what they’d pay for buying a drug with cash.

The Pharmaceutical Care Management Association, the industry group for PBMs, says it doesn't endorse gag clauses and that they are rare. 

But in a survey conducted by the NCPA in 2016, 39 percent of pharmacists said gag clauses prevented them from telling customers about cheaper alternatives between 10 and fifty times in the past month. 

“Prohibiting PBM 'gag clauses' will empower pharmacists to inform patients of lower prescription price options and help improve price transparency. Our members always want to assist their patients in receiving the affordable medications they need,” the American Pharmacists Association said in a statement. 

A recent study in the Journal of the American Medical Association reviewed 9.5 million insurance claims and found that 23 percent of prescriptions filled through insurance ended up costing more for customers than if they would have paid cash.

But pharmacists with these “gag clauses” in their contracts are unable to tell their customers this, or they could face severe penalties from PBMs. 

Bans on these clauses have grown in popularity at the state level, with at least 15 states enacting bans since 2017.

The popularity around banning gag clauses comes as anger surges about the rising cost of prescription drugs. 

More than 80 percent think the costs of prescription drugs are unreasonable, according to a recent poll from the Kaiser Family Foundation. 

The president and administrative officials have put PBMs in the hot seat over the practice. 

“This is a total rip-off and we are ending it,” President TrumpDonald John TrumpNFL freezes policy barring players from protesting during anthem McConnell spokesman on Putin visit: 'There is no invitation from Congress' Petition urges University of Virginia not to hire Marc Short MORE said last month during a speech on rising drug prices.  

Just this week, Health and Human Services Secretary Alex Azar said such clauses are “completely unacceptable.” 

Seema Verma, the administrator for the Centers for Medicare & Medicaid Services, issued a letter last month telling plans the agency will no longer tolerate gag clauses in Medicare drug plans.

“We want to make it clear that CMS finds any form of ‘gag clauses’ unacceptable and contrary to our efforts to promote drug price transparency and lower drug prices,” she wrote.